GlassScriptPhysician profile
Qasim Ghulam
NPI 1376119826
$9,502.83
in general payments reported to CMS, 2019-2025
15 companies · $2,939 in 2025
The $2,939 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $432 · 2022: $898 · 2023: $2,934 · 2024: $2,299 · 2025: $2,939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,966 · Food and Beverage: $3,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,965.80 |
| Food and Beverage | $3,206.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,533.92 | 2021-2025 | Insignia, Mako, T2 |
| Si-Bone, INC. | $2,244.00 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $1,752.23 | 2021-2025 | Affixus, Genex, Biomet Total Femur |
| Polynovo North America LLC | $430.80 | 2022-2025 | Novosorb Btm |
| Sanara Medtech INC. | $408.13 | 2023-2024 | Celleraterx |
| Axogen | $233.15 | 2024-2025 | Axoguard Nerve Cap, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Smith+Nephew, INC. | $194.75 | 2021-2022 | |
| Novus Surgical Consultants | $126.39 | 2022-2025 | |
| Davol INC. | $123.95 | 2022 | |
| Endo Pharmaceuticals INC. | $123.48 | 2022 | |
| Treace Medical Concepts, INC. | $123.15 | 2025 | |
| Aroa Biosurgery Incorporated | $87.14 | 2025 | |
| Integra Lifesciences Corporation | $65.64 | 2022 | |
| Cerapedics INC. | $38.22 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Depuy Synthes Sales INC. | $17.88 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qasim Ghulam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.